Chromosomal aberrations and risk of cancer in humans: An epidemiologic perspective

Cytogenetic and Genome Research

Volumn 104, Issue 1-4, 2004, Pages 376-382

  Bonassi, S ^a   Znaor, A ^b   Norppa, H ^c   Hagmar, L ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE MARKER; EPIDEMIOLOGICAL DATA; EVOLUTION; HUMAN; MEDICAL LITERATURE; MOLECULAR BIOLOGY; POLICY; POPULATION RESEARCH; PRIORITY JOURNAL; TECHNIQUE;

BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COHORT STUDIES; FOLLOW-UP STUDIES; FORECASTING; HUMANS; NEOPLASMS; RISK;

EID: 2642586416     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077519     Document Type: Conference Paper

References (30)

1. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A: IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111-172 (2000).
2. Bolognesi C, Abbondandolo A, Barale R, Casalone R, Dalpra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Migliore L, Padovani P, Pasquini R, Puntoni R, Sbrana I, Stella M, Bonassi S: Age-related increase of chromosome aberrations, sister-chromatid exchanges and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev 6:249-256 (1997).
3. Bonassi S: Combining environmental exposure and genetic effect measurements in health outcome assessment. Mutat Res 428:177-185 (1999).
4. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R: Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135 (1995a).
5. Bonassi S, Bolognesi C, Abbondandolo A, Barale R, Bigatti P, Camurri L, Dalpra L, De Ferrari M, Forni A, Lando C, Padovani P, Pasquini R, Stella M, Puntoni R: Influence of sex on cytogenetic endpoints: Evidence from a large human sample and review of the literature. Cancer Epidemiol Biomarkers Prev 4:671-679 (1995b).
6. Bonassi S, Hagmar L, Strömberg U, Huici Montagud A, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen I-L, Knudsen LE, Norppa H, for the European Study Group on Cytogenetic Biomarkers and Health (ESCH): Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res 60:1619-1625 (2000).
7. Boveri T: Zur Frage der Entstehung maligner Tumoren (Gustav Fisher, Jena 1914).
8. Dave BJ, Hopwood VL, Spitz MR, Pathak S: Shared cytogenetic abnormalities in lung tumours and corresponding peripheral blood lymphocytes. Int J Oncol 7:1297-1305 (1995).
9. Durante M, Bonassi S, George K, Cucinotta FA: Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res 156:662-667 (2001).
10. Hagmar L, Brøgger A, Hansteen I-L, Heim S, Högsted B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M: Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosomal damage. Cancer Res 54:2919-2922 (1994).
11. Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen L, Norppa H, Reuterwall C: Chromosomal aberrations in lymphocytes predict human cancer - A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117-4121 (1998).
12. Hande MP, Azizova TV, Gerad CR, Burak LE, Mitchell CR, Khokhryakov VF, Vasilenko EK, Brenner DJ: Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. Am J hum Genet 72:1162-1170 (2003).
13. Liou S-H, Lung J-C, Chen Y-H, Yang T, Hsieh L-L, Chen C-J, Wu T-N: Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 59:1481-1484 (1999).
14. Maffei F, Cantelli Forti G, Castelli E, Stefanini GF, Mattioli S, Hrelia P: Biomarkers to assess the genetic damage induced by alcohol abuse in human lymphocytes. Mutat Res 514:49-58 (2002).
15. Maierhofer C, Jentsch I, Lederer G, Fauth C, Speicher MR: Multicolor FISH in two and three dimensions for clastogenic analyses. Mutagenesis 17:523-527 (2002).
16. Nordic Study Group on the Health Risk of Chromosome Damage: An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Cancer Genet Cytogenet 45:85-92 (1990a).
17. Nordic Study Group on the Health Risk of Chromosome Damage: A Nordic data base on somatic chromosome damage in humans. Mutat Res 241:325-337 (1990b).
18. Norppa H: Cytogenetic biomarkers, in Boffeta P, Rice JM, Bird M, Buffler P (eds): Mechanistic Considerations in the Molecular Epidemiology of Cancer (IARC Sci Publ 157, Lyon 2004, in press).
19. Nowell P, Hungerford D: A minute chromosome in human granulocytic leukemia. Science 132:1497 (1960).
20. Perera FP: Molecular epidemiology: On the path to prevention? J natl Cancer Inst 92:601-612 (2000).
21. Peto J: Cancer epidemiology in the last century and the next decade. Nature 411:390-395 (2001).
22. Pfeiffer P, Goedecke W, Obe G: Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15:289-302 (2000).
23. Richardson C, Jasin M: Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405:697 (2000).
24. Rowley JD: The critical role of chromosome translocations in human leukemias. A Rev Genet 32:495-519 (1998).
25. Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, Pokorna Z, Mareckova, Hurychova D: Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ Health Perspect 109:41-45 (2001).
26. Smerhovsky Z, Landa K, Rössner P, Juzova D, Brabec M, Zudova Z, Hola N, Zarska H, Nevsimalova E: Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations. Mutat Res 514:165-176 (2002).
27. Taioli E, Bonassi S: Methodological issues in pooled analysis of biomarker studies. Mutat Res 512:85-92 (2002).
28. Tinnerberg H, Heikkilä P, Huici-Montagud A, Bernal F, Forni A, Wanders S, Welinder H, Wilhardt P, Strömberg U, Norppa H, Knudsen L, Bonassi S, Hagmar L: Retrospective exposure assessment and quality control in an international multicentre case control study. Ann Occup Hyg 47:37-47 (2003).
29. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H: Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 6:1003-1008 (2002).
30. Vilenchik MM, Knudson AG: Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer. Proc natl Acad Sci, USA 100:12871-12876 (2003).